Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2001;88:223-228

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deschepper, C. F.
Right arrow Articles by Reudelhuber, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deschepper, C. F.
Right arrow Articles by Reudelhuber, T. L.
Right arrowPubmed/NCBI databases
*Gene
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Hypertrophy
Right arrow Genetics of cardiovascular disease
Right arrow Animal models of human disease
(Circulation Research. 2001;88:223.)
© 2001 American Heart Association, Inc.


Molecular Medicine

Functional Alterations of the Nppa Promoter Are Linked to Cardiac Ventricular Hypertrophy in WKY/WKHA Rat Crosses

Christian F. Deschepper, Sandro Masciotra, Ahmad Zahabi, Isabelle Boutin-Ganache, Sylvie Picard, Timothy L. Reudelhuber

From the Laboratories of Experimental Cardiovascular Biology (C.F.D., S.M., A.Z., I.B.-G., S.P.) and Molecular Biology of Hypertension (T.L.R.), Institut de Recherches Cliniques de Montréal, Montréal, Québec, Canada.

Correspondence to Christian F. Deschepper, Experimental Cardiovascular Biology Laboratory, Institut de Recherches Cliniques de Montréal, 110 Pine Ave W, Montréal, Québec, H2W 1R7, Canada. E-mail deschec{at}ircm.qc.ca

Abstract—Cardiac left ventricular hypertrophy (LVH) is commonly associated with hypertension, but its variance is determined for more than 50% by blood pressure–independent genetic factors. Because it constitutes one of the most important risk factors for cardiovascular mortality, we have performed a genome-wide scan of the F2 progeny of crosses between inbred WKY and WKHA rats to detect quantitative trait loci (QTL) linked to cardiac mass. In addition to left ventricular mass (LVM), we also measured left ventricle (LV) concentration of atrial natriuretic factor (ANF), because we have previously established that there was a genetic link between these 2 traits in the same animal cross. We found 2 contiguous QTL on chromosome 5 that were linked to either LVM (logarithm of odds [LOD]=3.5) or logn (LV ANF) (LOD=12). The 1-LOD support intervals of both QTL shared a region overlapping the locus of natriuretic peptide precursor A (Nppa) (ie, the ANF-coding gene). We found by sequencing 2 single nucleotide polymorphisms (SNPs) within the first 650 bp of the Nppa minimal promoters of the genes from both strains. One of these SNPs increased the transcriptional activity of the Nppa minimal promoter in transfected neonatal cardiomyocytes in keeping with the higher LV concentration of ANF observed in WKY versus WKHA rats. Taken together with the previous reports showing that ANF may protect cardiomyocytes against hypertrophy, our genetic data single out Nppa as a strong candidate gene for the determination of LVM.


Key Words: left ventricular hypertrophy • genetics • atrial natriuretic factor • natriuretic peptide precursor A gene • quantitative trait locus




This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
B. Voigt, T. Kuramoto, T. Mashimo, T. Tsurumi, Y. Sasaki, R. Hokao, and T. Serikawa
Evaluation of LEXF/FXLE rat recombinant inbred strains for genetic dissection of complex traits
Physiol Genomics, February 19, 2008; 32(3): 335 - 342.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. G. Gardner, S. Chen, D. J. Glenn, and C. L. Grigsby
Molecular Biology of the Natriuretic Peptide System: Implications for Physiology and Hypertension
Hypertension, March 1, 2007; 49(3): 419 - 426.
[Full Text] [PDF]


Home page
Physiol. GenomicsHome page
C. Cerutti, M. Kurdi, G. Bricca, W. Hodroj, C. Paultre, J. Randon, and M.-P. Gustin
Transcriptional alterations in the left ventricle of three hypertensive rat models
Physiol Genomics, November 21, 2006; 27(3): 295 - 308.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. M. Palmer, Z. Chen, R. R. Lachapelle, E. D. Hendley, and M. M. LeWinter
Cardiomyocyte function associated with hyperactivity and/or hypertension in genetic models of LV hypertrophy
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H463 - H473.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. A. Babiker, L. J. De Windt, M. van Eickels, V. Thijssen, R. J.P. Bronsaer, C. Grohe, M. van Bilsen, and P. A. Doevendans
17{beta}-Estradiol Antagonizes Cardiomyocyte Hypertrophy by Autocrine/Paracrine Stimulation of a Guanylyl Cyclase A Receptor-Cyclic Guanosine Monophosphate-Dependent Protein Kinase Pathway
Circulation, January 20, 2004; 109(2): 269 - 276.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
M. R. Garrett and J. P. Rapp
Two closely linked interactive blood pressure QTL on rat chromosome 5 defined using congenic Dahl rats
Physiol Genomics, February 28, 2002; 8(2): 81 - 86.
[Abstract] [Full Text] [PDF]